Literature DB >> 12760292

Apoptosis regulation differs between ulcerative colitis-associated and sporadic colonic tumors. Association with survivin and bcl-2.

Tetuo Mikami1, Tsutomu Yoshida, Fumiyuki Akino, Tadashi Motoori, Mioko Yajima, Isao Okayasu.   

Abstract

To clarify kinetics in ulcerative colitis (UC)-associated lesions, cell proliferation, apoptosis, and expression of apoptosis-inhibitory proteins were studied. Ki-67 labeling and survivin and bcl-2 expression were examined immunohistochemically in 22 low-grade dysplasias (LGDs), 25 high-grade dysplasias (HGDs), and 13 adenocarcinomas associated with UC, and for comparison in 21 sporadic adenomas with LGD, 22 sporadic adenomas with HGD, and 21 invasive adenocarcinomas. Apoptosis was studied with nick-end labeling and immunohistochemical analysis of single-stranded DNA. In UC-associated LGDs, Ki-67--positive cells were more frequent in the lower than the upper half of the crypt, related to bcl-2 expression, while in sporadic adenomas such cells were more common in the upper half. No difference in apoptosis was found between UC-associated LGDs and sporadic adenomas with LGD or between UC-associated HGDs and sporadic adenomas with HGD. However, UC-associated carcinomas exhibited a lower apoptotic count than their sporadic invasive counterparts. This seemed related to higher survivin expression without a significant difference between the 2 types of invasive lesions regarding bcl-2 levels. Apoptosis is less frequent in UC-associated than in sporadic invasive colon carcinomas, this being linked to elevated survivin expression. The control of apoptosis may be different in the 2 types of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12760292     DOI: 10.1309/YLX4-L4H3-6K54-X92H

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Expression of Survivin in pancreatic cancer and its correlation to expression of Bcl-2.

Authors:  Jian-Guo Qiao; Yu-Qing Zhang; Yu-Chun Yin; Zui Tan
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

2.  Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.

Authors:  K Ishiguro; T Yoshida; H Yagishita; Y Numata; T Okayasu
Journal:  Gut       Date:  2005-12-14       Impact factor: 23.059

3.  Survivin expression can predict the effect of chemoradiotherapy for advanced lower rectal cancer.

Authors:  Chie Takasu; Mitsuo Shimada; Nobuhiro Kurita; Takashi Iwata; Hirohiko Sato; Masanori Nishioka; Shinya Morimoto; Kozo Yoshikawa; Tomohiko Miyatani; Hideya Kashihara; Tohru Utsunomiya; Hisanori Uehara
Journal:  Int J Clin Oncol       Date:  2012-08-31       Impact factor: 3.402

4.  Expression of the antiapoptotic protein survivin in colon cancer.

Authors:  Jonathan M Hernandez; Jeffrey M Farma; Domenico Coppola; Ardeshir Hakam; William J Fulp; Dung-Tsa Chen; Erin M Siegel; Timothy J Yeatman; David Shibata
Journal:  Clin Colorectal Cancer       Date:  2011-04-28       Impact factor: 4.481

5.  Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication.

Authors:  Masaaki Kobayashi; Satoru Hashimoto; Ken Nishikura; Ken-ichi Mizuno; Manabu Takeuchi; Yuichi Sato; Yoichi Ajioka; Yutaka Aoyagi
Journal:  J Gastroenterol       Date:  2013-02-19       Impact factor: 7.527

6.  Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis.

Authors:  Toshifumi Ohkusa; Tsutomu Yoshida; Nobuhiro Sato; Sumio Watanabe; Hisao Tajiri; Isao Okayasu
Journal:  J Med Microbiol       Date:  2009-05       Impact factor: 2.472

7.  Diagnostic performance of endoscopic classifications for neoplastic lesions in patients with ulcerative colitis: A retrospective case-control study.

Authors:  Yuichi Kida; Takeshi Yamamura; Keiko Maeda; Tsunaki Sawada; Eri Ishikawa; Yasuyuki Mizutani; Naomi Kakushima; Kazuhiro Furukawa; Takuya Ishikawa; Eizaburo Ohno; Hiroki Kawashima; Masanao Nakamura; Masatoshi Ishigami; Mitsuhiro Fujishiro
Journal:  World J Gastroenterol       Date:  2022-03-14       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.